Current attitudes to the therapy of vasculitis.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002309:Cardiology / Q000639:trends*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007239:Infections / Q000150:complications / Q000188:drug therapy; D011159:Population Surveillance; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014657:Vasculitis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D003520:Cyclophosphamide